As of April 16, 2025, Valneva SE (VALN) has a market cap of $0.57 billion USD. According to our data, Valneva SE is ranked No.5790 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.57 B |
61.25%
|
Dec 31, 2024 | $0.36 B |
-57.84%
|
Dec 29, 2023 | $0.84 B |
-18.48%
|
Dec 30, 2022 | $1.03 B |
-77.09%
|
Dec 31, 2021 | $4.51 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() Novavax
NVAX
|
$1.03 B |
0.000 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() Inovio Pharmaceuticals
INO
|
$64.55 M |
0.000 M
|
![]() USA
|
![]() Dynavax Technologies
DVAX
|
$1.42 B |
-0.000 M
|
![]() USA
|
![]() Vaxart
VXRT
|
$81.11 M |
-0.000 M
|
![]() USA
|
![]() Emergent BioSolutions
EBS
|
$0.25 B |
0.000 M
|
![]() USA
|
![]() Curevac
CVAC
|
$0.73 B |
0.000 M
|
![]() Germany
|
Market Cap | = | VALN Stock Price | * | VALN Shares Outstanding |
= | $7.05 | * | 81.20 M | |
= | $0.57 B |